Sopan Pharmaceuticals Limited
Strong pricing power (Gross margin 45.19%). Main risk: Expensive for the Manufacturing And Processing sector (1.83x its sector median of 180.22, 11 peers) (P/E 329.55). Technicals read Neutral.
9th of 13 in Manufacturing, by fundamental score
Last 75 trading days (adjusted close).
| Fiscal year | Cash | Bonus |
|---|---|---|
| 081-082 | 0.00% | 0.00% |
Interactive charts with ICT/SMC signals, the full rating breakdown, broker accumulation and portfolio tracking.
Open SOPL in the workspace →Market data is sourced from publicly available information and may be delayed. Ratings are algorithmic analysis, not investment advice. NepseFlow is not a licensed investment advisor.